Sutro Biopharma stock forecast
Want to see STRO full AI Analyst Report?
Sutro Biopharma (STRO) Stock Forecast & Price Target
STRO Analyst Ratings
STRO Stock 12 Month Forecast
Average Price Target
$45.25▲(385.52% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Yanan Zhu | Wells Fargo | $49 | buy | 425.75%Upside | Assigned | 11/16/26 | ||
| Lukas Shumway | Barclays | $56→$57 | buy | 511.59%Upside | Reiterated | 11/13/26 | ||
| David Nierengarten | Wedbush | $60→$25 | buy | 168.24%Upside | Reiterated | 11/13/26 | ||
| Andres Y. Maldonado | H.C. Wainwright | $50 | buy | 436.48%Upside | Reiterated | 11/13/26 | ||
| Laura Prendergast | Stifel Nicolaus | $48 | buy | 415.02%Upside | Reiterated | 08/17/26 | ||
| Tazeen Ahmad | Bank of America Securities | ― | sell | ― | Reiterated | 08/14/26 | ||
| Supawat Thongthip | Truist Financial | $50 | buy | 436.48%Upside | Reiterated | 08/13/26 | ||
| Charles Zhu | LifeSci Capital | $54 | buy | 479.40%Upside | Reiterated | 08/12/26 | ||
| Tara Bancroft | TD Cowen | ― | buy | ― | Reiterated | 08/12/26 | ||
| Andrew Berens | Leerink Partners | $38→$43 | buy | 361.37%Upside | Assigned | 05/15/26 | ||
| Joseph Catanzaro | Mizuho Securities | $50 | buy | 436.48%Upside | Initiated | 04/30/26 | ||
| Reni Benjamin | Citizens JMP | $35→$41 | buy | 339.91%Upside | Reiterated | 04/23/26 | ||
| James Shin | Deutsche Bank | $51→$55 | buy | 490.13%Upside | Reiterated | 03/25/26 | ||
| Edward Tenthoff | Piper Sandler | $20 | buy | 114.59%Upside | Reiterated | 12/04/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Yanan ZhuWells Fargo | BuyAssigned$49 | 11/16/26 | 425.75%Upside | ||
| Lukas ShumwayBarclays | BuyReiterated$56→$57 | 11/13/26 | 511.59%Upside | ||
| David NierengartenWedbush | BuyReiterated$60→$25 | 11/13/26 | 168.24%Upside | ||
| Andres Y. MaldonadoH.C. Wainwright | BuyReiterated$50 | 11/13/26 | 436.48%Upside | ||
| Laura PrendergastStifel Nicolaus | BuyReiterated$48 | 08/17/26 | 415.02%Upside | ||
| Tazeen AhmadBank of America Securities | SellReiterated | 08/14/26 | ― | ||
| Supawat ThongthipTruist Financial | BuyReiterated$50 | 08/13/26 | 436.48%Upside | ||
| Charles ZhuLifeSci Capital | BuyReiterated$54 | 08/12/26 | 479.40%Upside | ||
| Tara BancroftTD Cowen | BuyReiterated | 08/12/26 | ― | ||
| Andrew BerensLeerink Partners | BuyAssigned$38→$43 | 05/15/26 | 361.37%Upside | ||
| Joseph CatanzaroMizuho Securities | BuyInitiated$50 | 04/30/26 | 436.48%Upside | ||
| Reni BenjaminCitizens JMP | BuyReiterated$35→$41 | 04/23/26 | 339.91%Upside | ||
| James ShinDeutsche Bank | BuyReiterated$51→$55 | 03/25/26 | 490.13%Upside | ||
| Edward TenthoffPiper Sandler | BuyReiterated$20 | 12/04/25 | 114.59%Upside |
Best Analysts Covering Sutro Biopharma
Copying Reni Benjamin's trades and holding each position for 3 Months would result in 38.89% of your transactions generating a profit, with an average return of -8.58% per trade.
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -9.28% per trade.
Copying Tazeen Ahmad's trades and holding each position for 2 Years would result in 36.36% of your transactions generating a profit, with an average return of -9.17% per trade.
STRO Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 14 | 11 |
| Buy | 5 | 2 | 2 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 14 | 12 | 12 | 16 | 11 |
In the current month, STRO has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. STRO average Analyst price target in the past 3 months is 45.25.
STRO Financial Forecast
STRO Earnings Forecast
Next quarter’s earnings estimate for STRO is -$1.45 with a range of -$2.36 to $0.45. The previous quarter’s EPS was -$1.90. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
STRO Sales Forecast
Next quarter’s sales forecast for STRO is $14.17M with a range of $2.00M to $50.00M. The previous quarter’s sales results were $9.10M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

